SCHEMBL19203148

SCHEMBL19203148

Cc1cccc2c(C(=O)O)c(O)c(O)c(O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 10/20 0.49
LDHB P07195 9/20 0.49
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
KMT2A Q03164 1/20 0.45
DHODH Q02127 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ALB P02768 3/20 0.41
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19202314 0.89 LDHA (0.49) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL19203142 0.86 ALDH1A1 (0.47) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL19203144 0.86 ALDH1A1 (0.47) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL27918049 0.81 CA12 (0.54) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL19202316 0.79 CA12 (0.41) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL19195721 0.78 GLRA3 (0.51) LDHALDHBALDH1A1DHODHTDP1
SCHEMBL28260155 0.77 CYP3A4 (0.47) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL19203299 0.77 BCL2L1 (0.48) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL1905103 0.76 MCL1 (0.45) LDHALDHBALDH1A1KDM4EHPGD
SCHEMBL29260803 0.74 DHODH (0.55) LDHALDHBALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ORMCO CORPORATION 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE SP1, GPER1, GRIN1 LDHA 2656/4885LDHB 2298/4885ALDH1A1 1177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.